VA
Valmark Advisers’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $374K | Sell |
923
-30
| -3% | -$12.2K | 0.01% | 495 |
|
|
2025
Q1 | $474K | Sell |
953
-117
| -11% | -$58.2K | 0.01% | 437 |
|
|
2024
Q4 | $557K | Sell |
1,070
-226
| -17% | -$118K | 0.01% | 396 |
|
|
2024
Q3 | $801K | Buy |
1,296
+179
| +16% | +$111K | 0.01% | 340 |
|
|
2024
Q2 | $617K | Buy |
1,117
+413
| +59% | +$228K | 0.01% | 359 |
|
|
2024
Q1 | $409K | Buy |
704
+105
| +18% | +$61K | 0.01% | 409 |
|
|
2023
Q4 | $318K | Buy |
599
+17
| +3% | +$9.02K | 0.01% | 412 |
|
|
2023
Q3 | $295K | Sell |
582
-8
| -1% | -$4.05K | 0.01% | 397 |
|
|
2023
Q2 | $308K | Buy |
590
+39
| +7% | +$20.3K | 0.01% | 396 |
|
|
2023
Q1 | $318K | Buy |
551
+30
| +6% | +$17.3K | 0.01% | 384 |
|
|
2022
Q4 | $287K | Buy |
521
+56
| +12% | +$30.8K | 0.01% | 377 |
|
|
2022
Q3 | $236K | Buy |
465
+15
| +3% | +$7.61K | ﹤0.01% | 378 |
|
|
2022
Q2 | $244K | Sell |
450
-25
| -5% | -$13.6K | ﹤0.01% | 375 |
|
|
2022
Q1 | $281K | Buy |
475
+24
| +5% | +$14.2K | ﹤0.01% | 376 |
|
|
2021
Q4 | $301K | Sell |
451
-32
| -7% | -$21.4K | 0.01% | 346 |
|
|
2021
Q3 | $276K | Buy |
+483
| New | +$276K | 0.01% | 334 |
|